Latest Alzheimer's disease Stories
AGB101 could be the first drug to modify progression of amnestic mild cognitive impairment (aMCI) in patients at a high-risk for progressing to Alzheimer's dementia NEW YORK, Jan.
While the health-promoting qualities of wine have stolen the spotlight, it isn’t the only alcoholic beverage that can be good for you in some ways, according to a new study appearing in the latest edition of the Journal of Agricultural and Food Chemistry.
Phase 3-ready AGB101 designed to address aMCI, the pre-dementia stage of Alzheimer's Disease BALTIMORE, Jan.
Pines Education Institute of Southwest Florida, part of Pines of Sarasota, a not-for-profit outpatient and residential senior care center, will be presenting two hands-on dementia care workshops
Global research alliance ENIGMA finds 8 common gene mutations leading to brain age in over 30,000 brain scans that may one day unlock mysteries of Alzheimer's, autism and other neurological disorders
Award-winning MRM//McCann Completes Pro Bono Redesign of ALZinfo.org NEW YORK, Jan.
TauRx Publishes Positive Results of Phase II Clinical Trial in the Journal of Alzheimer's Disease ABERDEEN, Scotland and SINGAPORE, Jan.
WINSTON-SALEM, N.C., Jan.
The organization's new project, BELLA (Better Eyes for Longer Life without Alzheimer's), begins at New York's Somers Eye Center OSSINING, N.Y., Jan.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.